CYPHERPUNK TECHNOLOGIES INC. Operating Lease, Liability, Noncurrent
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Operating Lease, Liability, Noncurrent of $39.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2024-08-12
- 2024-06-30: Operating Lease, Liability, Noncurrent $39.00K.
- 2024-03-31: Operating Lease, Liability, Noncurrent $154.00K.
- 2023-06-30: Operating Lease, Liability, Noncurrent $38.00K.
- 2023-03-31: Operating Lease, Liability, Noncurrent $152.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2024-06-30 | $39.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $154.00K 10-Q · filed 2024-05-13 |
| 2023-06-30 | $38.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $152.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $262.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $369.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $474.00K 10-Q · filed 2022-08-12 |
| 2021-12-31 | $37.00K 10-K · filed 2023-03-24 |
| 2021-03-31 | $36.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $144.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $250.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $354.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $454.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $552.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $648.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $742.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $833.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |